相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

在胃癌中使用PARP抑制剂:解锁精密瘤学

Derek Tai¹, Vitor Goes², Sharanya Kumar³

¹Department of Internal Medicine, Loma Linda University Medical Center, Loma Linda, CA 92354, United States.

|September 19, 2025

概括

PARP 抑制剂在同源重组缺陷 (HRD) 的胃癌 (GC) 方面表现有前途. 改善的生物标志物对于选择患者和优化GC治疗中PARP抑制剂治疗至关重要.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
药理学药理学是指药理学的学科.

背景情况:

胃癌 (GC) 经常表现出同源重组修复 (HRR) 基因的改变.
临床前数据表明HRR缺乏 (HRD) 和PARP抑制剂 (PARPi) 之间的合成致死性.
在其他HRD癌症中PARPi的临床成功与由于异质性和生物标志物限制,在GC中不清楚的疗效形成鲜明对比.

研究的目的:

在HRR缺乏的GC中审查PARPi灵敏性的机制基础.
评估新兴生物标志物用于GC患者选择.
在GC管理中概述生物标记指导PARPi采用的战略.

主要方法:

机械学研究,临床试验和生物标志物研究的文献综述.
对基因组不稳定性得分,RAD51焦点,突变特征和候选HRR基因 (例如BRCA1/2,PALB2,BARD1) 的评估.
对患者选择和组合疗法策略的分析.

主要成果:

在GC中早期的PARPi单疗试验显示有效性有限,可能是由于可变的HRD和耐药机制.
基因组不稳定性,RAD51焦点和特定基因突变等生物标志物正在调查中.
组合策略 (化疗,免疫疗法,抗血管生成药物) 可能会提高PARPi的有效性.

结论:

精确识别HRD对于优化GC中的PARPi疗法至关重要.
需要以生物标志物为导向的方法来改善患者选择和治疗结果.
组合疗法是克服耐药性的有希望途径,并在GC中增强PARPi的疗效.

关键词:

在PARP中,PARP是PARP.这是一种PARP抑制剂.胃癌胃癌是一种胃癌.同类重组缺陷的同类重组缺陷精确瘤学精确瘤学

更多相关视频

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...